THORNE HEALTHTECH INC - COM (THRN)

CUSIP: 885260109

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / COM
Total 13F shares
4,780,431
Share change
+100
Total reported value
$22,095,238
Put/Call ratio
50%
Price per share
$4.62
Number of holders
43
Value change
+$256,488
Number of buys
26
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 885260109?
CUSIP 885260109 identifies THRN - THORNE HEALTHTECH INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THORNE HEALTHTECH INC - COM (THRN) as of Q1 2023

As of 31 Mar 2023, THORNE HEALTHTECH INC - COM (THRN) was held by 43 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,780,431 shares. The largest 10 holders included EMERALD ADVISERS, LLC, VANGUARD GROUP INC, EMERALD MUTUAL FUND ADVISERS TRUST, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, BANK OF AMERICA CORP /DE/, ROYCE & ASSOCIATES LP, MYDA Advisors LLC, STATE STREET CORP, and NORTHERN TRUST CORP. This page lists 43 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.